Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioCorRx (BICX) Profit After Tax (2016 - 2025)

BioCorRx (BICX) has disclosed Profit After Tax for 16 consecutive years, with -$471218.0 as the latest value for Q4 2025.

  • Quarterly Profit After Tax rose 62.91% to -$471218.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, up 133.45% year-over-year, with the annual reading at -$3.5 million for FY2025, 32.68% up from the prior year.
  • Profit After Tax hit -$471218.0 in Q4 2025 for BioCorRx, down from $1.4 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $1.4 million in Q2 2025 to a low of -$1.6 million in Q1 2021.
  • Historically, Profit After Tax has averaged -$887115.8 across 5 years, with a median of -$1.1 million in 2021.
  • Biggest five-year swings in Profit After Tax: crashed 74.44% in 2024 and later soared 211.61% in 2025.
  • Year by year, Profit After Tax stood at -$1.2 million in 2021, then grew by 3.2% to -$1.2 million in 2022, then increased by 16.68% to -$969009.0 in 2023, then tumbled by 31.12% to -$1.3 million in 2024, then surged by 62.91% to -$471218.0 in 2025.
  • Business Quant data shows Profit After Tax for BICX at -$471218.0 in Q4 2025, $1.4 million in Q2 2025, and $851764.0 in Q1 2025.